198 related articles for article (PubMed ID: 22320219)
1. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
[TBL] [Abstract][Full Text] [Related]
5. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
7. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
8. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).
Jagasia MH; Savani BN; Stricklin G; Engelhardt B; Kassim A; Dixon S; Chen H; Chinratanalab W; Goodman S; Greer JP; Schuening F
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1288-95. PubMed ID: 19747637
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology.
Tsirigotis P; Kaloyannidis P; Papalexandri A; Baltadakis I; Karakasis D; Batsis I; Sakellari I; Kitra V; Goussetis E; Papageorgiou S; Spyridonidis A; Graphakos S; Harhalakis N; Dervenoulas I; Anagnostopoulos A
Transfus Apher Sci; 2012 Apr; 46(2):173-80. PubMed ID: 22036202
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical outcome and survival in pediatric patients undergoing extracorporeal photopheresis for the treatment of steroid-refractory GVHD.
González Vicent M; Ramirez M; Sevilla J; Abad L; Díaz MA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):589-93. PubMed ID: 20962677
[TBL] [Abstract][Full Text] [Related]
12. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
Perseghin P; Galimberti S; Balduzzi A; Bonanomi S; Baldini V; Rovelli A; Dassi M; Rambaldi A; Castagna L; Corti P; Pogliani EM; Uderzo C
Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.
Ayuk F; Veit R; Zabelina T; Bussmann L; Christopeit M; Alchalby H; Wolschke C; Lellek H; Bacher U; Zander AR; Kröger N
Ann Hematol; 2015 Oct; 94(10):1727-32. PubMed ID: 26204824
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
18. New classification of chronic GVHD: added clarity from the consensus diagnoses.
Arora M; Nagaraj S; Witte J; DeFor TE; MacMillan M; Burns LJ; Weisdorf DJ
Bone Marrow Transplant; 2009 Jan; 43(2):149-53. PubMed ID: 18794869
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease: a prospective cohort study.
Arora M; Burns LJ; Davies SM; Macmillan ML; Defor TE; Miller WJ; Weisdorf DJ
Biol Blood Marrow Transplant; 2003 Jan; 9(1):38-45. PubMed ID: 12533740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
